Burlington (NYSE: BURL) insider files to sell 419 shares

Rhea-AI Filing Summary

Jennifer Vecchio filed a notice to sell 419 common shares of Burlington Stores, Inc. under Rule 144. The planned sale, through UBS Financial Services on the NYSE around February 2, 2026, has an aggregate market value of 123973.72, with 62,927,006 shares outstanding.

The 419 shares were acquired as RSUs on March 10, 2023 from the issuer. Over the past three months, Vecchio sold 419 common shares on each of November 3, 2025, December 1, 2025, and January 2, 2026, for gross proceeds of 115008.96, 103752.11, and 122560.81, respectively.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:05 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	419	123973.72	62927006	02/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2023	RSU	Issuer			419	03/10/2023	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jennifer Vecchio 1830 ROUTE 130 NORTH BURLINGTON NJ 08016	Common	12/01/2025	419	103752.11
Jennifer Vecchio 1830 ROUTE 130 NORTH BURLINGTON NJ 08016	Common	11/03/2025	419	115008.96
Jennifer Vecchio 1830 ROUTE 130 NORTH BURLINGTON NJ 08016	Common	01/02/2026	419	122560.81

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

Who is selling Burlington (BURL) shares in this Form 144 filing?

Jennifer Vecchio is the person for whose account Burlington common shares are to be sold. The filing lists her name and address and provides details on the planned Rule 144 sale, including share amount, broker, market, and recent sale history.

How many Burlington (BURL) shares are planned to be sold and through which broker?

The notice covers a planned sale of 419 common shares of Burlington Stores, Inc. The filing states that the transaction will be handled by UBS Financial Services, Inc. with the shares to be sold on the NYSE.

What is the aggregate market value of the Burlington (BURL) shares in this Form 144?

The filing shows an aggregate market value of 123,973.72 for the 419 Burlington common shares to be sold. It also notes that 62,927,006 shares of the issuer are outstanding at the time referenced.

How and when did the seller acquire the Burlington (BURL) shares being sold?

The 419 Burlington common shares to be sold were acquired on March 10, 2023 as an RSU award from the issuer. The filing lists the issuer as the source and indicates the same date for acquisition and payment.

What Burlington (BURL) share sales has the filer made in the past 3 months?

Over the past three months, the filer sold 419 common shares on each of November 3, 2025, December 1, 2025, and January 2, 2026, with gross proceeds of 115008.96, 103752.11, and 122560.81, respectively.

What does the Rule 144 representation in this Burlington (BURL) filing state?

The signer represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the representation language included for Rule 144 sales.